2016sharpbrainssummit_logo

HAPPYneuron at « SharpBrains Virtual Summit 2016 »

The « SharpBrains Virtual Summit » took place online from Dec 6th to Dec 8th. Speakers and attendees all connected to a virtual meeting room from all around the globe to participate in this major international event in Neuroscience.
The Summit featured over 30 of the world’s top scientists, innovators and experts working on ways to reinvent brain health in light of emerging science, technology, societal needs and market demand.
Franck Tarpin-Bernard, HAPPYneuron President, was happy to present HAPPYneuron’s strategy towards Health Care Professionals and its efforts to reach the high quality standards of Medical Devices. After explaining HAPPYneuron’s ISO13485 certification last May, Mr. Tarpin-Bernard showcased related partnerships finalized in 2016 with the pharma company Merck and the Ageing Well European leader Korian. He also presented the new platform that will be released shortly for French Health Care Professionals.

About SharpBrains:

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare market reports, publish consumer guides, produce an annual global and virtual professional conference and provide strategic advisory services.

SharpBrains.com, the firm’s educational blog and website, is one of the most popular brain blogs with 100,000+ monthly readers and 45,000+ eNewsletter subscribers. Our mission is to provide independent, research-based, information and guidance to navigate the growing cognitive and brain fitness market.

2016sharpbrainssummit_logo

illustration_1

Korian Cognitive Care by HappyNeuron

HappyNeuron has designed a specific program for Korian, the European leader in Ageing Well, to help slow down the cognitive decline of residents in their nursing homes.

This program called « Korian Cognitive Care by HappyNeuron » uses touch tablets to provide care teams with targeted, adapted and personalized cognitive stimulation tools for the residents based on their preserved abilities. It will be made available in all Korian facilities along with other non-drug treatments and recommendations for better care.

A first set of 60 facilities will be delivered and trained in the coming weeks. The complete roll-out in all Korian facilities is planned during 2017.

HappyNeuron Quality Management System is certified ISO13485.

About Korian:

The Korian group was created in 2001 and offers quality age care with over 71 500 beds in Europe (France, Germany, Belgium and Italy) and nearly 46 000 employees. The group manages nearly 600 nursing homes, 60 Assisted Living Facilities, 85 specialized clinics (post-acute and rehabilitation care clinics) and home care.

http://www.korian.com/

logo-merck

HAPPYneuron partners with « Merck KGaA » to offer the first cognitive remediation program for people living with Multiple Sclerosis.

After recently obtaining the ISO 13485 certification for its quality system management system for medical devices, HAPPYneuron is proud to announce its partnership with the renowned pharma lab Merck KGaA. HAPPYneuron grants an exclusive license on a cognitive training program for people living with Multiple Sclerosis (MS). This Class 1 medical device is available in Merck’s « MSDialog » platform when deemed beneficial for a patient by his/her healthcare provider.

For Merck KGaA : “The HAPPYneuron software-based cognitive training is backed by more than 10 years of clinical data and is designed to address cognitive function across various domains. HAPPYneuron’s suite of cognitive training games are designed to address the cognition challenges that people living with MS face, and the games automatically adjust skill to match the need of the individual — making the platform interesting for the patient and simple for healthcare professionals to use with their patients.” To access Merck’s press release.

HAPPYneuron is proud to contribute to this project designed to help people living with MS and confirms its expertise in cognitive remediation. Franck Tarpin-Bernard, HAPPYneuron President, says “This agreement is a strong acknowledgement of the hard work we have achieved these past years to build training programs adapted to the uniqueness of each medical condition. It reinforces our willingness to become a world leader of digital cognitive remediation.”

About Merck KGaA

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

msdialog

ISO_13485

HAPPYneuron Quality Management System passes the ISO 13485 certification of the Medical Device Industry

HAPPYneuron is proud to announce that its quality management system has just passed the ISO 13485 certification by Bureau Veritas Certification France for its ability to design, develop, sell and maintain Medical Devices for Cognitive Remediation and Rehabilitation and provide associated services.

This process enabled HAPPYneuron to register with the ANSM (the French National Agency of Security for Drugs and Health Products) its first class 1 medical device for cognitive remediation of patients suffering from multiple Sclerosis.

ISO 13485 is an International Organization for Standardization (ISO) standard, published in 2016, that represents the requirements for a comprehensive quality management system for the design and manufacture of medical devices. This standard extends the requirements of the more general ISO 9001 standard in the context of this industry.

Franck Tarpin-Bernard, HAPPYneuron President, indicates that «this certification acknowledges the work done on our quality management system for all our processes. Being the first French company in the Digital Brain Health market to achieve this certification, we are showing our determination to reinforce our medical positioning and to be an example in this young and growing industry. This is an additional guarantee for all our industrial partners and health care customers.»

HAPPYneuron will now engage in obtaining the equivalent standards in North America to facilitate its development in the US and Canada. Other medical devices are also being registered at the same time.

ISO_13485

ASHA-Logo

HAPPYneuron Pro exhibits at the ASHA Convention 2015

HAPPYneuron Pro will be attending the ASHA (American Speech and Hearing Association) annual convention in Denver, Colorado on November 12th to 14th, 2015. This event is the most important show for Speech and Language Therapists and Audiologists in the US.

This annual meeting gathers over 12,000 visitors and 300 exhibitors from all over the world and is a great opportunity to share and learn the last trends and evolution in this market. Change is a central theme of this event: « Changing Minds. Changing Lives. Leading the Way ».

HAPPYneuron Pro will be exhibiting during this 3-day event and presenting its latest products. The perfect place to continue its expansion in the US and promote HAPPYneuron worldwide.

Find out more in the detailed agenda of the convention: http://www.asha.org/Events/convention/Schedule

ASHA15banner

slideHome_MotusJoinHNpro_EN

HAPPYneuron acquires Motus

slideHome_MotusJoinHNpro_EN

HAPPYneuron is pleased to announce the acquisition of the Motus business in last July. With its commercial brand Orthomotus, this business has been very successfully editing digital Speech & Language assessment tools since several years. Among these is the very popular Exalang series, with 5 programs to evaluate Specific Learning Difficulties (SLD) of people from 3 to 20 years old.

These disorders affect 10% of the population and their diagnostic is a key public health issue. With this action, HAPPYneuron extends its area of activity and strengthens its offer in the assessment domain.

This operation is a great opportunity for HAPPYneuron to cover the entire range of care, from diagnostic to therapy, and to strengthen its leadership in the digital therapy solutions market.

Orthomotus products are currently only available in French. For more information, visit our French website at www.happyneuronpro.com.

CESD

CES-D, a Depression Screening App

HAPPYneuron, major actor in the field of cognitive remediation tools, along with Doctor Marc Willard, Psychiatrist, author of “Depression at the workplace”, and “Treating depression at the workplace with CBT” are proud to announce the release of the CES-D application to screen for depression.

Depression is a very frequent illness that can affect anybody. One person out of 5 will be affected during his/her lifetime. Its diagnosis is often late or unknown. However this illness can be treated efficiently with antidepressant or psychotherapy.

This CES-D application allows you to take a quick screening test, based on 20 questions taken from the most widely used auto-evaluation scale in depression epidemiology. This test does not provide a diagnosis, but can help detect potential depression-related disorders, with a simple self evaluation.

CES-D is available for free on Google Play and on the AppStore.

 

CESD

fusion-HN-et-Créa

HAPPYneuron merges with Créasoft

HAPPYneuron merges with Créasoft

In 2015, HAPPYneuron and Créasoft, both subsidiaries of SBT’s “Smart Health” are merging in order to develop joint products and offer the best to their customers.HAPPYneuron now has 3 main offers:

  • My HAPPYneuron for the general public:  www.myhappyneuron.fr
  • HAPPYneuron Pro for health professionals, speech therapists and the healthy aging sector
  • HAPPYneuron Solutions for large companies in the pharmaceutical and insurance industries.

The entire team at HAPPYneuron wishes you a happy and stimulating 2015.

Click to view video

Carte de voeux US

Conf2

HAPPYneuron is partner of the scientific conference on cognitive remediation in New York

On June 6th 2014 in New York was held the 17th annual conference on “Cognitive Remediation in Psychiatry”. This international conference, organized by the Columbia University, brings together researchers, physicians, organizations and companies from all around the world.

HAPPYneuron is proud to have taken part in this event and in discussions on various topics relating to social and cognitive remediation for people with psychiatric disorders.

The event’s program included presentations by researchers on their experiences and research findings about cognitive remediation, themed workshops, training on remediation, and many poster presentations on current and future research.

Chris Bowie, professor and researcher at Queens University in Canada, presented the preliminary results of a recent study using our tools as part of a program to help people with schizophrenia in their professional lives.

Isabelle Amado from the Saint-Anne hospital in Paris, was also awarded a prize entitled “Science to Practice” for her invaluable contribution to cognitive remediation and its expansion in France, Europe and internationally.

Many workshops were also held, and SBTpro was mentioned and recognized as one of the essential tools for cognitive remediation.

HAPPYneuron was pleased to sponsor this event to support research in this area and to advance the knowledge and use of these treatments for Schizophrenia.

Conference

broca activation

New Publication, Recos efficacy

Recognition of the effectiveness of our cognitive remediation software for schizophrenia patients (RECOS) has just entered another stage. Indeed, Pascal Vianin, co-author of the software, has just published an article in Psychiatry Research: Neuroimaging, supported by medical imaging, shows an increase in activity in the Broca’s area of the brain in patients using our software compared with patients not using it.

The treatment lasts 14 weeks. Although group size remains too small (2 x 8 people) for scientists to categorically say that the results are indisputable, it is the first time that we can literally see the effect of using our tools on the brain.

Réf:

Pascal Vianin, Sébastien Urben, Pierre Magistretti, Pierre Marquet, Eleonora Fornari, Laure Jaugey, Increased activation in Broca's area after cognitive remediation in schizophrenia, Psychiatry Research: Neuroimaging, Volume 221, Issue 3, 30 March 2014, Pages 204-209, ISSN 0925-4927, http://dx.doi.org/10.1016/j.pscychresns.2014.01.004.
(http://www.sciencedirect.com/science/article/pii/S0925492714000055)

broca activation